Mission
ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
Staff Only
Directory
| President | |
| Name | Title |
| Steven D. Pearson, MD., MSc., FRCP | President |
| Staff | |
| Name | Title |
| Daniel A. Ollendorf, MPH, ARM | Chief Review Officer |
| Katy Marttila, BA | Program Manager |
| Marc D. Silverstein, MD FACP | Chief Decision Scientist |
| Mary Ann (M. A.) Ladd, BS | Systems Manager |
| Sarah K. Emond, MPP | Chief Operating Officer |
| Tanya Bobo, MS, MPH | Senior Technology Analyst |
| Affiliated Researchers Act as technical leaders on the specification, estimation, and analysis of results of the economic modeling component of each ICER appraisal | |
| Name | Title |
| Alexander Göhler, MD, PhD, MSc, MPH | Senior Scientist, Institute for Technology Assessment |
| Amy Knudsen, PhD | Senior Scientist, Institute for Technology Assessment |
| Joseph Ladapo, MD, PhD | Alumnus, Institute for Technology Assessment |
| Julia Hayes, MD | Institute for Technology Assessment |
| Pamela McMahon, PhD | Associate Director, Institute for Technology Assessment |